The adoption of artificial intelligence has evolved with investment shifting from monitoring to predictive intelligence, according to the 2025 LogiPharma AI Report.
The deal grants Andelyn’s gene therapy clients with access to Solid’s capsid in combination with the CDMO’s suspension and adherent platform manufacturing process.
The cross-disciplinary panel is meant to provide independent recommendations and governance guidance to Fujifilm’s life sciences and healthcare subsidiaries.
